Coronavirus Disease (COVID)-19 and Diabetic Kidney Disease.

Srivastava, Swayam Prakash; Srivastava, Rohit; Chand, Subhash; Goodwin, Julie E

Srivastava, Swayam Prakash; Srivastava, Rohit; Chand, Subhash; Goodwin, Julie E.

Afiliación

Srivastava SP; Department of Pediatrics, Yale University School of Medicine, New Haven, CT 06520, USA.
Srivastava R; Vascular Biology and Therapeutics Program, Yale University School of Medicine, New Haven, CT 06511, USA.
Chand S; Laboratory of Medical Transcriptomics, Department of Endocrinology, Nephrology Services, Hadassah Hebrew-University Medical Center, Jerusalem 91905, Israel.
Goodwin JE; Department of Anesthesiology, University of Nebraska Medical Center, Omaha, NE 68198, USA.

Pharmaceuticals (Basel) ; 14(8)2021 Jul 30.

Article en En | MEDLINE | ID: mdl-34451848

Palabras clave

ACE2; AMP-activated protein kinase (AMPK); COVID-19 associated nephropathy; LncRNAs; angiotensin-converting enzyme (ACE); circular RNAs; coronavirus disease (COVID)-19; diabetes; diabetic kidney disease; dipeptidyl peptidase (DPP)-4; endothelial-to-mesenchymal transition; epithelial-to-mesenchymal transition; kidney diseases; microRNAs; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Pharmaceuticals (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google